This is a Validated Antibody Database (VAD) review about mouse Car9, based on 13 published articles (read how Labome selects the articles), using Car9 antibody in all methods. It is aimed to help Labome visitors find the most suited Car9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Car9 synonym: CAIX; Ca9; MN/CA9

Novus Biologicals
domestic rabbit polyclonal (OTI2B3)
  • immunohistochemistry; human; loading ...; fig 6d
Novus Biologicals Car9 antibody (Novus Biologicals, NB100-417) was used in immunohistochemistry on human samples (fig 6d). Sci Adv (2021) ncbi
domestic rabbit polyclonal (OTI2B3)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3a
Novus Biologicals Car9 antibody (Novus Biologicals, NB100-417) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3a). NPJ Breast Cancer (2021) ncbi
domestic rabbit polyclonal (OTI2B3)
  • western blot; human; 1:5000; loading ...; fig 1f
Novus Biologicals Car9 antibody (Novus, NB100-417) was used in western blot on human samples at 1:5000 (fig 1f). EMBO Mol Med (2018) ncbi
domestic rabbit polyclonal (OTI2B3)
  • western blot; human; fig 13
Novus Biologicals Car9 antibody (Novus Biologicals, NB100-417) was used in western blot on human samples (fig 13). PLoS ONE (2016) ncbi
domestic rabbit polyclonal (OTI2B3)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 6
In order to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma, Novus Biologicals Car9 antibody (Novus Biologicals, #NB100?\417) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 6). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal (OTI2B3)
  • western blot; human; 1:1000; fig 4
In order to investigate factors that control PHD1 activity, Novus Biologicals Car9 antibody (Novus Biologicals, NB100-417) was used in western blot on human samples at 1:1000 (fig 4). J Cell Sci (2016) ncbi
domestic rabbit polyclonal (OTI2B3)
  • immunocytochemistry; Xenopus laevis; 1:500; fig 5c
  • western blot; Xenopus laevis; 1:500; fig 1e
  • immunocytochemistry; human; 1:500; loading ...; fig 5a
Novus Biologicals Car9 antibody (Novus Biologicals, NB100-417) was used in immunocytochemistry on Xenopus laevis samples at 1:500 (fig 5c), in western blot on Xenopus laevis samples at 1:500 (fig 1e) and in immunocytochemistry on human samples at 1:500 (fig 5a). FEBS J (2016) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig s5c
Abcam Car9 antibody (abcam, ab184006) was used in immunohistochemistry on human samples (fig s5c). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2g
Abcam Car9 antibody (Abcam, ab15086) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2g). Cancer Res (2021) ncbi
mouse monoclonal (2D3)
  • immunohistochemistry - paraffin section; human; 1:80; loading ...; fig 4a
Abcam Car9 antibody (Abcam, ab107257) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 4a). Oncol Rep (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 3a
  • immunohistochemistry; human; loading ...; fig 5a
  • western blot; human; loading ...; fig 6d, s2c
Abcam Car9 antibody (Abcam, ab184006) was used in immunocytochemistry on human samples (fig 3a), in immunohistochemistry on human samples (fig 5a) and in western blot on human samples (fig 6d, s2c). Sci Adv (2019) ncbi
Invitrogen
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:2000; loading ...; fig 2a
Invitrogen Car9 antibody (Thermo Fisher Scientific, PA1-16592) was used in immunohistochemistry on mouse samples at 1:2000 (fig 2a). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig s4a
Invitrogen Car9 antibody (Invitrogen, PA1-16592) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig s4a). J Clin Invest (2021) ncbi
Articles Reviewed
  1. Hoefflin R, Harlander S, Abhari B, Peighambari A, Adlesic M, Seidel P, et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2021;13: pubmed publisher
  2. Wang Y, Lyu Y, Tu K, Xu Q, Yang Y, Salman S, et al. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization. Sci Adv. 2021;7: pubmed publisher
  3. Ashok C, Ahuja N, Natua S, Mishra J, Samaiya A, Shukla S. E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression. Oncogenesis. 2021;10:58 pubmed publisher
  4. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  5. Steenbrugge J, Vander Elst N, Demeyere K, De Wever O, Sanders N, van den Broeck W, et al. OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. NPJ Breast Cancer. 2021;7:27 pubmed publisher
  6. Peck B, Bland P, Mavrommati I, Muirhead G, Cottom H, Wai P, et al. 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer. Cancer Res. 2021;81:847-859 pubmed publisher
  7. Chen W, Li W, Bai B, Wei H. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma. Oncol Rep. 2020;43:817-826 pubmed publisher
  8. Li J, Shi K, Sabet Z, Fu W, Zhou H, Xu S, et al. New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy. Sci Adv. 2019;5:eaax0937 pubmed publisher
  9. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed publisher
  10. Ono M, Yamada K, Bensaddek D, Afzal V, Biddlestone J, Ortmann B, et al. Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1α Protein Replacement Human Cell Lines. PLoS ONE. 2016;11:e0154759 pubmed publisher
  11. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed publisher
  12. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed publisher
  13. Klier M, Jamali S, Ames S, Schneider H, Becker H, Deitmer J. Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly. FEBS J. 2016;283:191-200 pubmed publisher